StockData
Palvella Therapeutics, Inc. logo

Palvella Therapeutics, Inc. (PVLA) stock

PVLANasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 7/30
$144.35−0.25 (-0.17%)

Close on Nov 17, 2026Market cap $2.08BP/E –Yield –

Palvella Therapeutics EV/EBITDA

EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.

Palvella Therapeutics's EV/EBITDA was 0.6× on Nov 29, 2024.

EV/EBITDA at the end of each year

PeriodPeriod endValueChange (pts)
2024Nov 29, 20240.6×–

More Palvella Therapeutics figures

See a number that looks wrong?